Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2

Several existing drugs have gained initial consideration due to their therapeutic characteristics against COVID-19 (Corona Virus Disease 2019). Hydroxychloroquine (HCQ) was proposed as possible therapy for shortening the duration of COVID-19, but soon after this, it was discarded. Similarly, known a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Avinash, Rathore, Anurag S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742708/
https://www.ncbi.nlm.nih.gov/pubmed/35000060
http://dx.doi.org/10.1007/s11030-021-10358-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742708/
https://www.ncbi.nlm.nih.gov/pubmed/35000060
http://dx.doi.org/10.1007/s11030-021-10358-5

Ejemplares similares